Highlights from the Podium and In the News
Publication of Immunological and Histologic Results in Stem Cell Reports
Publication of Immunological and Histologic Results in Stem Cell Reports
Publication of Immunological and Histologic Results in Stem Cell Reports
Publication of immunological and histologic results from the Phase 1/2a clinical trial of the CPCB-RPE1 implant for advanced, dry age-related macular degeneration, entitled, “Survival of an HLA-mismatched, Bioengineered RPE Implant in Dry Age-Related Macular Degeneration,” published online in Stem Cell Reports
Press Release 4 February 2022
Publication of Immunological and Histologic Results in Stem Cell Reports
Publication of Immunological and Histologic Results in Stem Cell Reports
Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular Degeneration.
Presentation at 2022 OIS Innovation Summit
Publication of Immunological and Histologic Results in Stem Cell Reports
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
Dr. Suber Huang presented the RPT study at the 2022 OIS Innovation Summit in San Antonio
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
THE STEM CELLAR How a tiny patch is helping restore lasting vision
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
Publication of the one year follow-up results from our Phase 1/2a clinical trial in dry age-related macular degeneration - In a Special Issue of Translational Vision Science & Technology (tvst)
RPT Featured in Ophthalmology Times
THE STEM CELLAR How a tiny patch is helping restore lasting vision
THE STEM CELLAR How a tiny patch is helping restore lasting vision
February 8, 2022, by David Hutton
Discovery by USC investigators shows long-term viability of stem cell derived retinal implant
THE STEM CELLAR How a tiny patch is helping restore lasting vision
THE STEM CELLAR How a tiny patch is helping restore lasting vision
THE STEM CELLAR How a tiny patch is helping restore lasting vision
Read the latest blog post (or listen on Spotify) profiling our program on THE STEM CELLAR, The Official Blog of CIRM, California's Stem Cell Agency.
RPT Presentation at Angiogenesis 2022 Featured in Modern Retina
RPT Presentation at Angiogenesis 2022 Featured in Modern Retina
RPT Presentation at Angiogenesis 2022 Featured in Modern Retina
Dr. Amir Kashani presented results of the RPT study at the Angiogenesis 2022 conference. His Presentation was featured in Modern Retina, Feb 11, 2022
Publication in Scientific Reports
RPT Presentation at Angiogenesis 2022 Featured in Modern Retina
RPT Presentation at Angiogenesis 2022 Featured in Modern Retina
In a paper published in the journal Scientific Reports, RPT scientists in collaboration with colleagues at the University of California Santa Barbara and the University of Southern California report a novel cryopreservation technique that facilitates long-term storage of RPT’s CPCB-RPE1 ocular implants. This technique will greatly enhance the ability to widely distribute the implants and increase the number AMD patients that are able to receive the treatment.
Publication in Science and Translational Medicine
RPT Presentation at Angiogenesis 2022 Featured in Modern Retina
Publication in Science and Translational Medicine
Publication of preliminary results from our Phase 1/2a clinical trial in dry age-related macular degeneration - The cover story in Science Translational Medicine
AARP - Medical Breakthroughs of 2020
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Publication in Science and Translational Medicine
AARP highlights RPT Study participant in: Saving Their Health and Ours. Medical Breakthroughs of 2020
First Step
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
A video produced by the Roski Eye Institute - highlighting the first implant procedure
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
A participant in our clinical trial shares her story.
RPT Stem Cell Patch Profiled on Futurity
Clinical Trial Close-Up in the latest issue of Retina Specialist
Clinical Trial Close-Up in the latest issue of Retina Specialist
Read the full article on Futurity where Researcher Mohamed Faynus discusses how the RPT stem cell-derived retinal patch survived two years post-implantation, without triggering immune rejection.
Clinical Trial Close-Up in the latest issue of Retina Specialist
Clinical Trial Close-Up in the latest issue of Retina Specialist
Clinical Trial Close-Up in the latest issue of Retina Specialist
Read the full article in the Sept/Oct 2021 issue of Retina Specialist where Richard Mark Kirkner interviews Dr. Amir Kashani, about the technology and the clinical investigation.
Press Release 21 June 2021
Clinical Trial Close-Up in the latest issue of Retina Specialist
THE STEM CELLAR Sometimes a cold stare is a good thing
Regenerative Patch Technologies Reports Latest Findings from Phase 1/2a Clinical Trial at 2021 International Society of Stem Cell Research Annual Meeting
THE STEM CELLAR Sometimes a cold stare is a good thing
THE STEM CELLAR Sometimes a cold stare is a good thing
THE STEM CELLAR Sometimes a cold stare is a good thing
Read the latest blog post (or listen on Spotify) profiling our program on THE STEM CELLAR, The Official Blog of CIRM, California's Stem Cell Agency.
University of California Santa Barbara - The Current
THE STEM CELLAR Sometimes a cold stare is a good thing
University of California Santa Barbara - The Current
In an article for UCSB - The Current, Britney Pennington and Lincoln Johnson discuss how novel cryopreservation methods enable long-term storage and worldwide distribution of a cellular therapy for age-related macular degeneration.
Vision for the Future: Stem Cell Therapy for Eye Disease
Vision for the Future: Stem Cell Therapy for Eye Disease
Vision for the Future: Stem Cell Therapy for Eye Disease
RPT co-founder Dr. Dennis Clegg describes the recent strategies to develop a regenerative patch for the treatment of age-related macular degeneration by developing a cellular therapy using stem cells.
TEDx talk - Stemming Vision Loss with Stem Cells
Vision for the Future: Stem Cell Therapy for Eye Disease
Vision for the Future: Stem Cell Therapy for Eye Disease
TEDx talk - Stemming Vision Loss with Stem Cells- RPT co-founder Dr. Dennis Clegg
Featured in National Geographic
Featured in National Geographic
Featured in National Geographic
Why There’s New Hope About Ending Blindness
The Story of Sight
Featured in National Geographic
Featured in National Geographic
Highlighted in the documentary Story of Sight